Evidence map›Paper›PMID 35130329›Full record

ArticlePLoS pathogens2022

SPCS1-Dependent E2-p7 processing determines HCV Assembly efficiency.

Nabeel Alzahrani, Ming-Jhan Wu, Carla F Sousa, Olga V Kalinina, Christoph Welsch, MinKyung Yi

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nabeel AlzahraniDepartment of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Ming-Jhan WuDepartment of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.ORCID 0000-0003-2778-977X
Carla F SousaDrug Bioinformatics Group, HIPS, HZI, Saarbrücken, Germany.ORCID 0000-0002-6735-3455
Olga V KalininaDrug Bioinformatics Group, HIPS, HZI, Saarbrücken, Germany.
Christoph WelschDepartment of Internal Medicine 1, Goethe University Hospital, Frankfurt am Main, Germany.
MinKyung YiDepartment of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.ORCID 0000-0002-5978-2452
The University of Texas Medical Branch at Galveston · USHelmholtz Institute for Pharmaceutical Research Saarland · DEGoethe University Frankfurt · DE

Funding

Mechanistic function of HCV NS5A targeted by the potent inhibitorsR01AI146227 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YI, MINKYUNG · 2020 to 2024
$2.8M
Mechanisms of HCV AssemblyR01AI110358 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YI, MINKYUNG · 2015 to 2019
$1.9M
NIAID NIH HHS R01 AI110358NIAID NIH HHS R01 AI146227
6 · The paper itself

Abstract

Recent studies identified signal peptidase complex subunit 1 (SPCS1) as a proviral host factor for Flaviviridae viruses, including HCV. One of the SPCS1's roles in flavivirus propagation was attributed to its regulation of signal peptidase complex (SPC)-mediated processing of flavivirus polyprotein, especially C-prM junction. However, whether SPCS1 also regulates any SPC-mediated processing sites within HCV polyprotein remains unclear. In this study, we determined that loss of SPCS1 specifically impairs the HCV E2-p7 processing by the SPC. We also determined that efficient separation of E2 and p7, regardless of its dependence on SPC-mediated processing, leads to SPCS1 dispensable for HCV assembly These results suggest that SPCS1 regulates HCV assembly by facilitating the SPC-mediated processing of E2-p7 precursor. Structural modeling suggests that intrinsically delayed processing of the E2-p7 is likely caused by the structural rigidity of p7 N-terminal transmembrane helix-1 (p7/TM1/helix-1), which has mostly maintained membrane-embedded conformations during molecular dynamics (MD) simulations. E2-p7-processing-impairing p7 mutations narrowed the p7/TM1/helix-1 bending angle against the membrane, resulting in closer membrane embedment of the p7/TM1/helix-1 and less access of E2-p7 junction substrate to the catalytic site of the SPC, located well above the membrane in the ER lumen. Based on these results we propose that the key mechanism of action of SPCS1 in HCV assembly is to facilitate the E2-p7 processing by enhancing the E2-p7 junction site presentation to the SPC active site. By providing evidence that SPCS1 facilitates HCV assembly by regulating SPC-mediated cleavage of E2-p7 junction, equivalent to the previously established role of this protein in C-prM junction processing in flavivirus, this study establishes the common role of SPCS1 in Flaviviridae family virus propagation as to exquisitely regulate the SPC-mediated processing of specific, suboptimal target sites.

Indexed as

Virus AssemblyCell LineHEK293 CellsHepacivirusHepatitis CHost Microbial InteractionsHumansMembrane ProteinsMolecular Dynamics SimulationProtein ConformationViral Envelope ProteinsViroporin ProteinsVirus Replicationglycoprotein E2, Hepatitis C virusMembrane Proteinsp7 protein, Hepatitis C virussignal peptidase complex subunit 1, humanViral Envelope ProteinsViroporin Proteins

Identifiers

PMID35130329
PMCPMC8853643
OpenAlexW4210819462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.